These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1372 related items for PubMed ID: 22759450

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D, Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology, Technology Assessment Committee of the Society of Interventional Radiology.
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [Abstract] [Full Text] [Related]

  • 3. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW, Kim KJ, Noh WY, Jang MS, Yang MH, Han MK, Kwon OK, Jung C, Kim JH, Oh CW, Lee JS, Lee J, Bae HJ.
    Cerebrovasc Dis; 2013 Aug; 35(5):461-8. PubMed ID: 23735898
    [Abstract] [Full Text] [Related]

  • 4. Safety and effectiveness of endovascular treatment after 6 hours of symptom onset in patients with anterior circulation ischemic stroke: a matched case control study.
    Qureshi AI, Miley JT, Chaudhry SA, Semaan E, Rodriguez GJ, Suri MF, Adams HP.
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1076-81. PubMed ID: 23099041
    [Abstract] [Full Text] [Related]

  • 5. Results of intravenous thrombolysis within 4.5 to 6 hours and updated results within 3 to 4.5 hours of onset of acute ischemic stroke recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR): an observational study.
    Ahmed N, Kellert L, Lees KR, Mikulik R, Tatlisumak T, Toni D, SITS Investigators.
    JAMA Neurol; 2013 Jul; 70(7):837-44. PubMed ID: 23689267
    [Abstract] [Full Text] [Related]

  • 6. Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator.
    Derex L, Nighoghossian N, Hermier M, Adeleine P, Berthezène Y, Philippeau F, Honnorat J, Froment JC, Trouillas P.
    J Neurol Sci; 2004 Oct 15; 225(1-2):3-9. PubMed ID: 15465079
    [Abstract] [Full Text] [Related]

  • 7. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A, Epstein D, Cohen D, Bathula R, Devine J, Kar A, Taube D, Duncan N, Ames D.
    Cerebrovasc Dis; 2013 Oct 15; 35(1):45-52. PubMed ID: 23428996
    [Abstract] [Full Text] [Related]

  • 8. Magnetic resonance imaging-based versus computed tomography-based thrombolysis in acute ischemic stroke: comparison of safety and efficacy within a cohort study.
    Gerischer LM, Fiebach JB, Scheitz JF, Audebert HJ, Endres M, Nolte CH.
    Cerebrovasc Dis; 2013 Oct 15; 35(3):250-6. PubMed ID: 23548768
    [Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of MRI-based thrombolysis in unclear-onset stroke. A preliminary report.
    Cho AH, Sohn SI, Han MK, Lee DH, Kim JS, Choi CG, Sohn CH, Kwon SU, Suh DC, Kim SJ, Bae HJ, Kang DW.
    Cerebrovasc Dis; 2008 Oct 15; 25(6):572-9. PubMed ID: 18483457
    [Abstract] [Full Text] [Related]

  • 10. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusion<or=3 h and 3-6 h.
    Li YH, Li MH, Zhao ZG, Bai QK.
    Neurol India; 2009 Oct 15; 57(4):426-33. PubMed ID: 19770543
    [Abstract] [Full Text] [Related]

  • 11. SYNTHESIS expansion: design of a nonprofit, pragmatic, randomized, controlled trial on the best fast-track endovascular treatment vs. standard intravenous alteplase for acute ischemic stroke.
    Ciccone A, Valvassori L, Nichelatti M, SYNTHESIS Expansion investigators.
    Int J Stroke; 2011 Jun 15; 6(3):259-65. PubMed ID: 21557814
    [Abstract] [Full Text] [Related]

  • 12. Intravenous thrombolysis for acute cerebral ischemia in Belgrade, Serbia: comparison with Lille, France.
    Bogosavljevic V, Bodenant M, Beslac-Bumbasirevic L, Cordonnier C, Jovanovic DR, Budimkic M, Leys D.
    Eur Neurol; 2011 Jun 15; 66(1):30-6. PubMed ID: 21709419
    [Abstract] [Full Text] [Related]

  • 13. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S, Deguchi K, Morimoto N, Kurata T, Deguchi S, Yamashita T, Ikeda Y, Matsuura T, Narai H, Omori N, Manabe Y, Yunoki T, Takao Y, Kawata S, Kashihara K, Abe K.
    J Stroke Cerebrovasc Dis; 2013 Apr 15; 22(3):190-6. PubMed ID: 21968092
    [Abstract] [Full Text] [Related]

  • 14. A multicenter, randomized, controlled study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits with Intra-Arterial therapy (EXTEND-IA).
    Campbell BC, Mitchell PJ, Yan B, Parsons MW, Christensen S, Churilov L, Dowling RJ, Dewey H, Brooks M, Miteff F, Levi C, Krause M, Harrington TJ, Faulder KC, Steinfort BS, Kleinig T, Scroop R, Chryssidis S, Barber A, Hope A, Moriarty M, McGuinness B, Wong AA, Coulthard A, Wijeratne T, Lee A, Jannes J, Leyden J, Phan TG, Chong W, Holt ME, Chandra RV, Bladin CF, Badve M, Rice H, de Villiers L, Ma H, Desmond PM, Donnan GA, Davis SM, EXTEND-IA investigators.
    Int J Stroke; 2014 Jan 15; 9(1):126-32. PubMed ID: 24207098
    [Abstract] [Full Text] [Related]

  • 15. Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: the ICARO-2 study.
    Paciaroni M, Agnelli G, Caso V, Pieroni A, Bovi P, Cappellari M, Zini A, Nichelli P, Inzitari D, Nesi M, Nencini P, Pezzini A, Padovani A, Tassinari T, Orlandi G, Chiti A, Gialdini G, Alberti A, Venti M, Acciarresi M, D'Amore C, Luda E, Tassi R, Martini G, Ferrarese C, Beretta S, Trentini C, Silvestrelli G, Lanari A, Previdi P, Ciccone A, Delodovici ML, Bono G, Galletti G, Marcheselli S, Del Sette M, Traverso E, Riva M, Silvestrini M, Cerqua R, Consoli D, Monaco S, Toni D.
    Cerebrovasc Dis; 2012 Jan 15; 34(5-6):430-5. PubMed ID: 23207482
    [Abstract] [Full Text] [Related]

  • 16. TESPI (Thrombolysis in Elderly Stroke Patients in Italy): a randomized controlled trial of alteplase (rt-PA) versus standard treatment in acute ischaemic stroke in patients aged more than 80 years where thrombolysis is initiated within three hours after stroke onset.
    Lorenzano S, Toni D, TESPI trial Investigators.
    Int J Stroke; 2012 Apr 15; 7(3):250-7. PubMed ID: 22292526
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Role of tissue plasminogen activator in acute ischemic stroke.
    Hatcher MA, Starr JA.
    Ann Pharmacother; 2011 Mar 15; 45(3):364-71. PubMed ID: 21386027
    [Abstract] [Full Text] [Related]

  • 19. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T, Suarez JI, Tarr RW, Welter E, Landis D, Sunshine JL, Zaidat OO.
    J Stroke Cerebrovasc Dis; 2008 Mar 15; 17(3):121-8. PubMed ID: 18436152
    [Abstract] [Full Text] [Related]

  • 20. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
    Seet RC, Rabinstein AA.
    Cerebrovasc Dis; 2012 Mar 15; 34(2):106-14. PubMed ID: 22868870
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 69.